A single intraperitoneal injection of STZ in mice resulted in metabolic phenotypes that are characteristics of human T1D, including increased blood glucose and serum triglyceride content, decreased serum insulin, and lower body weight (Figures 1(a)–1(d) and Table S1). The gene discussed is INS; the disease is type 1 diabetes mellitus.